A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
To assess the safety and local tolerability of BBI-4000 15% gel compared with vehicle
(placebo) when applied topically once daily in subjects with palmar hyperhidrosis.